Bone Cement And Glue Market

By Product Type;

Synthetic Bone Glue and Natural Bone Glue

By Application;

Arthroplasty, Total Knee Arthroplasty, Total Hip Arthroplasty, Total Shoulder Arthroplasty, Kyphoplasty, and Vertebroplasty

By End User;

Hospitals, Ambulatory Surgery Centers (ASCs), and Clinics/Physician Offices

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn448331165 Published Date: August, 2025

Bone Cement & Glue Market Overview

Bone Cement & Glue Market (USD Million)

Bone Cement & Glue Market was valued at USD 1,208.80 million in the year 2024. The size of this market is expected to increase to USD 1,781.88 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.7%.


Bone Cement And Glue Market

*Market size in USD million

CAGR 5.7 %


Study Period2025 - 2031
Base Year2024
CAGR (%)5.7 %
Market Size (2024)USD 1,208.80 Million
Market Size (2031)USD 1,781.88 Million
Market ConcentrationMedium
Report Pages302
1,208.80
2024
1,781.88
2031

Major Players

  • Stryker
  • Zimmer Biomet
  • Depuy Synthes
  • Smith & Nephew
  • Arthrex
  • DJO Global
  • Exactech
  • Teknimed
  • Heraeus Medical
  • Cryolife
  • Cardinal Health
  • Trimph

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Bone Cement And Glue Market

Fragmented - Highly competitive market without dominant players


The Bone Cement And Glue Market is witnessing steady growth, largely driven by the rising incidence of hormone-dependent conditions such as prostate cancer, endometriosis, and uterine fibroids. As a potent gonadotropin-releasing hormone (GnRH) agonist, leuprolide acetate plays a critical role in regulating hormone production, making it a preferred treatment in both oncology and reproductive health. Notably, prostate cancer therapies account for nearly 60% of leuprolide acetate's overall clinical use, underlining its vital role in modern medical protocols.

Increasing Preference for Hormone-Based Therapies
The market is also benefiting from the broader acceptance of hormone therapies due to their precision in treating specific conditions and delivering favorable outcomes. As patient and provider awareness increases, there is a growing shift toward therapies that offer targeted hormone suppression. Current data suggests that hormone therapy prescriptions now represent over 45% of treatments for reproductive health disorders, reflecting this trend toward more specialized pharmacological solutions.

Innovations in Drug Delivery Systems
Technological advancements in drug formulations are significantly shaping the future of this market. Long-acting injectable formats and depot systems have gained popularity for their convenience and improved adherence. In fact, nearly 35% of new drug innovations in this segment emphasize extended-release mechanisms, which help maintain therapeutic levels in the body while reducing the need for frequent dosing. These improvements are enhancing treatment efficacy and patient experience.

Supportive Healthcare Policies and Regulations
Governmental support and evolving healthcare policies are further stimulating market expansion. Investments in reproductive and cancer-related healthcare programs are making leuprolide acetate therapies more accessible and affordable. Presently, more than 40% of chronic disease management programs integrate hormone-based treatment approaches, highlighting the regulatory push toward comprehensive and inclusive care strategies.

Growth Trajectory and Market Potential
With its versatile applications and strong clinical reputation, the leuprolide acetate market is expected to grow steadily in the years ahead. Ongoing clinical research, increasing healthcare investments, and strategic industry collaborations are creating a fertile landscape for innovation.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By Application
    3. Market Snapshot, By End User
    4. Market Snapshot, By Region
  4. Bone Cement & Glue Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Aging population
        2. Increasing prevalence of musculoskeletal disorders
        3. Technological advancements in biomaterials
        4. Rising demand for minimally invasive surgeries
      2. Restraints
        1. High cost of advanced bone cement and glue products
        2. Regulatory challenges and product approval processes
        3. Complications associated with cemented implants
        4. Limited reimbursement policies in certain regions
      3. Opportunities
        1. Development of antibiotic-loaded bone cement
        2. Expansion into emerging markets
        3. Growing adoption of biocompatible and bioresorbable materials
        4. Integration of 3D printing technology in product manufacturing
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Bone Cement & Glue Market, By Product Type, 2021 - 2031 (USD Million)
      1. Synthetic Bone Glue
      2. Natural Bone Glue
    2. Bone Cement & Glue Market, By Application, 2021 - 2031 (USD Million)
      1. Arthroplasty
      2. Total Knee Arthroplasty
      3. Total Hip Arthroplasty
      4. Total Shoulder Arthroplasty
      5. Kyphoplasty
      6. Vertebroplasty
    3. Bone Cement & Glue Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Ambulatory Surgery Centers
      3. Clinics/Physician Offices
    4. Bone Cement & Glue Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Stryker
      2. Zimmer Biomet
      3. Depuy Synthes
      4. Smith & Nephew
      5. Arthrex
      6. DJO Global
      7. Exactech
      8. Teknimed
      9. Heraeus Medical
      10. Cryolife
      11. Cardinal Health
      12. Trimph
  7. Analyst Views
  8. Future Outlook of the Market